Skip to main content
. 2012 Feb 6;2012:342796. doi: 10.5402/2012/342796

Table 4.

QLQ-BLM30

QLQ-BLM30 Ileal conduit
Mean ± standard dev.
Median (interquartile range)
n = number of cases
Ileal neobladder
Mean ± standard dev.
Median (interquartile range)
n = number of cases
Urinary symptom 33.6 ± 26.3
33.3 (9.5–52.4)
n = 33
Urostomy problem 25.6 ± 22.0
19.4 (6.9–43.8)
n = 24
Single catheter use problem 0 ± 0 6.7 ± 14.9
0 (0-0) 0 (0–16.7)
n = 1 n = 5
Future perspective 39.1 ± 33.8 24.3 ± 27.9
33.3 (11.1–66.7) 11.1 (0–44.4)
n = 23 n = 32
Abdominal bloating and flatulence 28.3 ± 25.8 29.7 ± 31.0
33.3 (0–50.0) 16.7 (0–50)
n = 23 n = 32
Body image 34.1 ± 32.3 33.5 ± 28.2
22.2 (11.1–55.6) 33.3 (11.1–55.6)
n = 23 n = 32
Sexual functioning no available data no available data

EORTC QLQ-BLM30 results of this study. The questionnaire is a phase-3 module that specifically evaluates the impact of radical cystectomy and reconstructive surgery in terms of health-related quality of life. For all the questions, a scale from 1 to 4 was used (1: not at all, 2: a little, 3: quite a bit, 4: very much). All scores were linearly transformed such that all scales range from 0 to 100. For the symptoms/single items, a higher score means a higher level of symptomatology/problems.